Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy: Results From a Danish Multicentre Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy : Results From a Danish Multicentre Study. / Lawaetz, Martin; Sandholt, Benjamin; Eilersen, Emilie N.; Petersen, Christian; Tørslev, Katrine; Shilenok, Dmitriy; Houlind, Kim C.; Sillesen, Henrik; Shahidi, Saeid; Rathenborg, Lisbet K.; Eiberg, Jonas.

I: European Journal of Vascular and Endovascular Surgery, Bind 62, Nr. 2, 2021, s. 160-166.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Lawaetz, M, Sandholt, B, Eilersen, EN, Petersen, C, Tørslev, K, Shilenok, D, Houlind, KC, Sillesen, H, Shahidi, S, Rathenborg, LK & Eiberg, J 2021, 'Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy: Results From a Danish Multicentre Study', European Journal of Vascular and Endovascular Surgery, bind 62, nr. 2, s. 160-166. https://doi.org/10.1016/j.ejvs.2021.04.016

APA

Lawaetz, M., Sandholt, B., Eilersen, E. N., Petersen, C., Tørslev, K., Shilenok, D., Houlind, K. C., Sillesen, H., Shahidi, S., Rathenborg, L. K., & Eiberg, J. (2021). Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy: Results From a Danish Multicentre Study. European Journal of Vascular and Endovascular Surgery, 62(2), 160-166. https://doi.org/10.1016/j.ejvs.2021.04.016

Vancouver

Lawaetz M, Sandholt B, Eilersen EN, Petersen C, Tørslev K, Shilenok D o.a. Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy: Results From a Danish Multicentre Study. European Journal of Vascular and Endovascular Surgery. 2021;62(2):160-166. https://doi.org/10.1016/j.ejvs.2021.04.016

Author

Lawaetz, Martin ; Sandholt, Benjamin ; Eilersen, Emilie N. ; Petersen, Christian ; Tørslev, Katrine ; Shilenok, Dmitriy ; Houlind, Kim C. ; Sillesen, Henrik ; Shahidi, Saeid ; Rathenborg, Lisbet K. ; Eiberg, Jonas. / Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy : Results From a Danish Multicentre Study. I: European Journal of Vascular and Endovascular Surgery. 2021 ; Bind 62, Nr. 2. s. 160-166.

Bibtex

@article{55f50a9e3ee84d5b8def0f90077b4102,
title = "Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy: Results From a Danish Multicentre Study",
abstract = "Objective: The risk of ipsilateral neurological recurrence (NR) was assessed in patients awaiting carotid endarterectomy (CEA) due to symptomatic carotid artery stenosis and whether current national guidelines of performing CEA within 14 days are adequate in present day practice. Methods: This was a retrospective multicentre observational cohort study. Patients scheduled for CEA due to symptomatic carotid artery stenosis in a five year period, 1 January 2014 to 31 December 2018, from four centres were included. Data from the Danish Vascular Registry (www.karbase.dk), operative managing systems, and electronic medical records were reviewed. Results: In total, 1 125 patients scheduled for CEA were included and 1 095 (97%) underwent the planned surgery. During a median delay from index event to CEA of 11 days (interquartile range 8–16 days), 40 patients (3.6%; 95% confidence interval [CI] 2.5%–5%) experienced a NR. One third were minor strokes (n = 12, 30%); half were transient ischaemic attacks (TIA) (n = 22, 55%); and amaurosis fugax accounted for 15% (n = 6). Twenty-six (2%) CEA procedures was cancelled, of which one was due to a disabling recurrent ischaemic event (aphasia). There were no deaths or major strokes in the waiting time for CEA. Best medical treatment (BMT) with platelet inhibitory or anticoagulation drugs and a statin was initiated in nearly all patients (98%) at first assessment. The overall 30 day risk of a post-operative major event (death or stroke) was (Kaplan–Meier [KM] estimate) 2.7% (95% CI 1.8–3.8), and not significantly correlated with the timing of surgery. Most (69%) occurred within the first three days. One, two, and three year mortality rate for CEA patients was (KM estimate) 4.8%, 7.8%, and 11.5% respectively. Conclusion: In symptomatic carotid artery stenosis patients awaiting CEA, very few NRs occurred within 14 days. Institution of immediate BMT in specialised TIA/stroke units followed by early, but not necessarily urgent, CEA is a reasonable course of action in patients with high grade symptomatic carotid artery stenosis.",
keywords = "Carotid artery, Carotid stenosis, Endarterectomy, NR, Recurrent event, Stroke",
author = "Martin Lawaetz and Benjamin Sandholt and Eilersen, {Emilie N.} and Christian Petersen and Katrine T{\o}rslev and Dmitriy Shilenok and Houlind, {Kim C.} and Henrik Sillesen and Saeid Shahidi and Rathenborg, {Lisbet K.} and Jonas Eiberg",
note = "Publisher Copyright: {\textcopyright} 2021 European Society for Vascular Surgery",
year = "2021",
doi = "10.1016/j.ejvs.2021.04.016",
language = "English",
volume = "62",
pages = "160--166",
journal = "European Journal of Vascular and Endovascular Surgery",
issn = "1078-5884",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy

T2 - Results From a Danish Multicentre Study

AU - Lawaetz, Martin

AU - Sandholt, Benjamin

AU - Eilersen, Emilie N.

AU - Petersen, Christian

AU - Tørslev, Katrine

AU - Shilenok, Dmitriy

AU - Houlind, Kim C.

AU - Sillesen, Henrik

AU - Shahidi, Saeid

AU - Rathenborg, Lisbet K.

AU - Eiberg, Jonas

N1 - Publisher Copyright: © 2021 European Society for Vascular Surgery

PY - 2021

Y1 - 2021

N2 - Objective: The risk of ipsilateral neurological recurrence (NR) was assessed in patients awaiting carotid endarterectomy (CEA) due to symptomatic carotid artery stenosis and whether current national guidelines of performing CEA within 14 days are adequate in present day practice. Methods: This was a retrospective multicentre observational cohort study. Patients scheduled for CEA due to symptomatic carotid artery stenosis in a five year period, 1 January 2014 to 31 December 2018, from four centres were included. Data from the Danish Vascular Registry (www.karbase.dk), operative managing systems, and electronic medical records were reviewed. Results: In total, 1 125 patients scheduled for CEA were included and 1 095 (97%) underwent the planned surgery. During a median delay from index event to CEA of 11 days (interquartile range 8–16 days), 40 patients (3.6%; 95% confidence interval [CI] 2.5%–5%) experienced a NR. One third were minor strokes (n = 12, 30%); half were transient ischaemic attacks (TIA) (n = 22, 55%); and amaurosis fugax accounted for 15% (n = 6). Twenty-six (2%) CEA procedures was cancelled, of which one was due to a disabling recurrent ischaemic event (aphasia). There were no deaths or major strokes in the waiting time for CEA. Best medical treatment (BMT) with platelet inhibitory or anticoagulation drugs and a statin was initiated in nearly all patients (98%) at first assessment. The overall 30 day risk of a post-operative major event (death or stroke) was (Kaplan–Meier [KM] estimate) 2.7% (95% CI 1.8–3.8), and not significantly correlated with the timing of surgery. Most (69%) occurred within the first three days. One, two, and three year mortality rate for CEA patients was (KM estimate) 4.8%, 7.8%, and 11.5% respectively. Conclusion: In symptomatic carotid artery stenosis patients awaiting CEA, very few NRs occurred within 14 days. Institution of immediate BMT in specialised TIA/stroke units followed by early, but not necessarily urgent, CEA is a reasonable course of action in patients with high grade symptomatic carotid artery stenosis.

AB - Objective: The risk of ipsilateral neurological recurrence (NR) was assessed in patients awaiting carotid endarterectomy (CEA) due to symptomatic carotid artery stenosis and whether current national guidelines of performing CEA within 14 days are adequate in present day practice. Methods: This was a retrospective multicentre observational cohort study. Patients scheduled for CEA due to symptomatic carotid artery stenosis in a five year period, 1 January 2014 to 31 December 2018, from four centres were included. Data from the Danish Vascular Registry (www.karbase.dk), operative managing systems, and electronic medical records were reviewed. Results: In total, 1 125 patients scheduled for CEA were included and 1 095 (97%) underwent the planned surgery. During a median delay from index event to CEA of 11 days (interquartile range 8–16 days), 40 patients (3.6%; 95% confidence interval [CI] 2.5%–5%) experienced a NR. One third were minor strokes (n = 12, 30%); half were transient ischaemic attacks (TIA) (n = 22, 55%); and amaurosis fugax accounted for 15% (n = 6). Twenty-six (2%) CEA procedures was cancelled, of which one was due to a disabling recurrent ischaemic event (aphasia). There were no deaths or major strokes in the waiting time for CEA. Best medical treatment (BMT) with platelet inhibitory or anticoagulation drugs and a statin was initiated in nearly all patients (98%) at first assessment. The overall 30 day risk of a post-operative major event (death or stroke) was (Kaplan–Meier [KM] estimate) 2.7% (95% CI 1.8–3.8), and not significantly correlated with the timing of surgery. Most (69%) occurred within the first three days. One, two, and three year mortality rate for CEA patients was (KM estimate) 4.8%, 7.8%, and 11.5% respectively. Conclusion: In symptomatic carotid artery stenosis patients awaiting CEA, very few NRs occurred within 14 days. Institution of immediate BMT in specialised TIA/stroke units followed by early, but not necessarily urgent, CEA is a reasonable course of action in patients with high grade symptomatic carotid artery stenosis.

KW - Carotid artery

KW - Carotid stenosis

KW - Endarterectomy

KW - NR

KW - Recurrent event

KW - Stroke

U2 - 10.1016/j.ejvs.2021.04.016

DO - 10.1016/j.ejvs.2021.04.016

M3 - Journal article

C2 - 34127375

AN - SCOPUS:85107907222

VL - 62

SP - 160

EP - 166

JO - European Journal of Vascular and Endovascular Surgery

JF - European Journal of Vascular and Endovascular Surgery

SN - 1078-5884

IS - 2

ER -

ID: 273651416